221 related articles for article (PubMed ID: 17254575)
21. The human immunodeficiency virus Vpr protein binds Cdc25C: implications for G2 arrest.
Goh WC; Manel N; Emerman M
Virology; 2004 Jan; 318(1):337-49. PubMed ID: 14972559
[TBL] [Abstract][Full Text] [Related]
22. Protein methylation is required to maintain optimal HIV-1 infectivity.
Willemsen NM; Hitchen EM; Bodetti TJ; Apolloni A; Warrilow D; Piller SC; Harrich D
Retrovirology; 2006 Dec; 3():92. PubMed ID: 17169163
[TBL] [Abstract][Full Text] [Related]
23. ATR and GADD45alpha mediate HIV-1 Vpr-induced apoptosis.
Andersen JL; Zimmerman ES; DeHart JL; Murala S; Ardon O; Blackett J; Chen J; Planelles V
Cell Death Differ; 2005 Apr; 12(4):326-34. PubMed ID: 15650754
[TBL] [Abstract][Full Text] [Related]
24. Interaction between the HIV-1 protein Vpr and the adenine nucleotide translocator.
Sabbah EN; Druillennec S; Morellet N; Bouaziz S; Kroemer G; Roques BP
Chem Biol Drug Des; 2006 Feb; 67(2):145-54. PubMed ID: 16492162
[TBL] [Abstract][Full Text] [Related]
25. HIV-1 Vpr regulates expression of beta chemokines in human primary lymphocytes and macrophages.
Muthumani K; Kudchodkar S; Papasavvas E; Montaner LJ; Weiner DB; Ayyavoo V
J Leukoc Biol; 2000 Sep; 68(3):366-72. PubMed ID: 10985253
[TBL] [Abstract][Full Text] [Related]
26. Heat shock protein 70 protects cells from cell cycle arrest and apoptosis induced by human immunodeficiency virus type 1 viral protein R.
Iordanskiy S; Zhao Y; Dubrovsky L; Iordanskaya T; Chen M; Liang D; Bukrinsky M
J Virol; 2004 Sep; 78(18):9697-704. PubMed ID: 15331702
[TBL] [Abstract][Full Text] [Related]
27. The mitochondriotoxic domain of Vpr determines HIV-1 virulence.
Brenner C; Kroemer G
J Clin Invest; 2003 May; 111(10):1455-7. PubMed ID: 12750393
[No Abstract] [Full Text] [Related]
28. Analysis of HIV-1 Vpr determinants responsible for cell growth arrest in Saccharomyces cerevisiae.
Yao XJ; Rougeau N; Duisit G; Lemay J; Cohen EA
Retrovirology; 2004 Aug; 1():21. PubMed ID: 15312229
[TBL] [Abstract][Full Text] [Related]
29. HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitro.
Muthumani K; Hwang DS; Choo AY; Mayilvahanan S; Dayes NS; Thieu KP; Weiner DB
Int Immunol; 2005 Feb; 17(2):103-16. PubMed ID: 15611322
[TBL] [Abstract][Full Text] [Related]
30. Direct Vpr-Vpr interaction in cells monitored by two photon fluorescence correlation spectroscopy and fluorescence lifetime imaging.
Fritz JV; Didier P; Clamme JP; Schaub E; Muriaux D; Cabanne C; Morellet N; Bouaziz S; Darlix JL; Mély Y; de Rocquigny H
Retrovirology; 2008 Sep; 5():87. PubMed ID: 18808682
[TBL] [Abstract][Full Text] [Related]
31. The C-terminal moiety of HIV-1 Vpr induces cell death via a caspase-independent mitochondrial pathway.
Roumier T; Vieira HL; Castedo M; Ferri KF; Boya P; Andreau K; Druillennec S; Joza N; Penninger JM; Roques B; Kroemer G
Cell Death Differ; 2002 Nov; 9(11):1212-9. PubMed ID: 12404120
[TBL] [Abstract][Full Text] [Related]
32. Increased levels of Wee-1 kinase in G(2) are necessary for Vpr- and gamma irradiation-induced G(2) arrest.
Yuan H; Kamata M; Xie YM; Chen IS
J Virol; 2004 Aug; 78(15):8183-90. PubMed ID: 15254189
[TBL] [Abstract][Full Text] [Related]
33. Biochemical mechanisms of HIV induced T cell apoptosis.
Selliah N; Finkel TH
Cell Death Differ; 2001 Feb; 8(2):127-36. PubMed ID: 11313714
[No Abstract] [Full Text] [Related]
34. HIV-1 Vpr induces DNA double-strand breaks.
Tachiwana H; Shimura M; Nakai-Murakami C; Tokunaga K; Takizawa Y; Sata T; Kurumizaka H; Ishizaka Y
Cancer Res; 2006 Jan; 66(2):627-31. PubMed ID: 16423988
[TBL] [Abstract][Full Text] [Related]
35. Flying in the face of resistance: antiviral-independent benefit of HIV protease inhibitors on T-cell survival.
Vlahakis SR; Bren GD; Algeciras-Schimnich A; Trushin SA; Schnepple DJ; Badley AD
Clin Pharmacol Ther; 2007 Sep; 82(3):294-9. PubMed ID: 17361127
[TBL] [Abstract][Full Text] [Related]
36. CpG protects human monocytic cells against HIV-Vpr-induced apoptosis by cellular inhibitor of apoptosis-2 through the calcium-activated JNK pathway in a TLR9-independent manner.
Saxena M; Busca A; Pandey S; Kryworuchko M; Kumar A
J Immunol; 2011 Dec; 187(11):5865-78. PubMed ID: 22068233
[TBL] [Abstract][Full Text] [Related]
37. Residues within the HFRIGC sequence of HIV-1 vpr involved in growth arrest activities.
Berglez JM; Castelli LA; Sankovich SA; Smith SC; Curtain CC; Macreadie IG
Biochem Biophys Res Commun; 1999 Oct; 264(1):287-90. PubMed ID: 10527879
[TBL] [Abstract][Full Text] [Related]
38. Intranuclear binding by the HIV-1 regulatory protein VPR is dependent on cytosolic factors.
Jans DA; Jans P; Jülich T; Briggs LJ; Xiao CY; Piller SC
Biochem Biophys Res Commun; 2000 Apr; 270(3):1055-62. PubMed ID: 10772949
[TBL] [Abstract][Full Text] [Related]
39. HIV-1 Vpr-induced cell death in Schizosaccharomyces pombe is reminiscent of apoptosis.
Huard S; Chen M; Burdette KE; Fenyvuesvolgyi C; Yu M; Elder RT; Zhao RY
Cell Res; 2008 Sep; 18(9):961-73. PubMed ID: 19160543
[TBL] [Abstract][Full Text] [Related]
40. HIV-1 Vpr enhances production of receptor of activated NF-kappaB ligand (RANKL) via potentiation of glucocorticoid receptor activity.
Fakruddin JM; Laurence J
Arch Virol; 2005 Jan; 150(1):67-78. PubMed ID: 15449141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
